Variant report

Variant	nsv435787
Chromosome Location	chr4:103325955-103332407
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr4:103307851..103309753-chr4:103332388..103335045,2	MCF-7	breast:
2	chr4:103318667..103321583-chr4:103325673..103327605,2	K562	blood:
3	chr4:103321154..103323341-chr4:103327192..103329685,2	K562	blood:

Extended variants
information (count: 535 )
Associated
traits (count: 76 )

Variant overlapped rSNPs/rCNVs (count:535 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs576411666	chr4:103325957-103325958	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs192218887	chr4:103325965-103325966	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs566481781	chr4:103325981-103325982	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs538644169	chr4:103325992-103325993	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs1462944	chr4:103326002-103326003	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs62328473	chr4:103326044-103326045	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs72928338	chr4:103326060-103326061	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs545530669	chr4:103326084-103326085	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs1462945	chr4:103326097-103326098	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs13134240	chr4:103326112-103326113	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs543132050	chr4:103326156-103326157	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs561418927	chr4:103326162-103326163	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs557595346	chr4:103326171-103326172	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs76877526	chr4:103326179-103326180	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs78958132	chr4:103326184-103326185	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs4464574	chr4:103326211-103326212	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs530235751	chr4:103326232-103326233	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs72928340	chr4:103326259-103326260	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs560664316	chr4:103326313-103326314	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs184544339	chr4:103326314-103326315	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs575713095	chr4:103326340-103326341	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs1462946	chr4:103326351-103326352	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs546496039	chr4:103326424-103326425	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs552316534	chr4:103326460-103326461	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs564663570	chr4:103326546-103326547	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs188254903	chr4:103326575-103326576	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs531703023	chr4:103326616-103326617	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs550317884	chr4:103326679-103326680	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs140165248	chr4:103326722-103326723	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs111823684	chr4:103326723-103326724	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs536314056	chr4:103326754-103326755	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs568517723	chr4:103326854-103326855	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs373353606	chr4:103326893-103326894	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs535652998	chr4:103326897-103326898	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs148464609	chr4:103326903-103326904	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs553920869	chr4:103326930-103326931	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs565865923	chr4:103326958-103326959	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs181858743	chr4:103327007-103327008	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs73834800	chr4:103327069-103327070	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs12508086	chr4:103327149-103327150	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
41	rs35467980	chr4:103327178-103327179	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs561303039	chr4:103327181-103327182	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs12508121	chr4:103327207-103327208	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs78146941	chr4:103327226-103327227	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs573392604	chr4:103327228-103327229	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs542106005	chr4:103327255-103327256	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs73834802	chr4:103327261-103327262	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs142604834	chr4:103327329-103327330	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs546490065	chr4:103327343-103327344	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs73837203	chr4:103327375-103327376	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:76)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Breast cancer	16272173	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Myelodysplastic syndrome	21251322	CNVD
Lung cancer	18438408	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	21183584	CNVD
primary effusion lymphomas	17116491	CNVD
small cell lung cancer	20016488	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	17133270	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	20459617	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Breast cancer	17393978	CNVD
Ovarian cancer	21720365	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Esophageal cancer	21851588	CNVD
Prostate cancer	16573809	CNVD
Multiple myeloma	16616336	CNVD
Melanoma	20688739	CNVD
Breast cancer	16397240	CNVD
Acute myeloid leukemia	18000384	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Myelofibrosis	22110671	CNVD
myeloid cancer	21057493	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:23 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:103317200-103327400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
2	chr4:103323400-103328400	Weak transcription	Psoas Muscle	Psoas
3	chr4:103323800-103326200	Enhancers	Primary monocytes fromperipheralblood	blood
4	chr4:103325000-103341600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
5	chr4:103325200-103327400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
6	chr4:103325600-103328600	Enhancers	Hela-S3	cervix
7	chr4:103325800-103326400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
8	chr4:103325800-103326400	Enhancers	Monocytes-CD14+_RO01746	blood
9	chr4:103327400-103327600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
10	chr4:103327400-103332200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
11	chr4:103327800-103328000	Enhancers	Monocytes-CD14+_RO01746	blood
12	chr4:103328000-103328200	Enhancers	Primary monocytes fromperipheralblood	blood
13	chr4:103328000-103332200	Weak transcription	Monocytes-CD14+_RO01746	blood
14	chr4:103328200-103332200	Weak transcription	Primary monocytes fromperipheralblood	blood
15	chr4:103328400-103328600	Enhancers	Psoas Muscle	Psoas
16	chr4:103328600-103332200	Weak transcription	Hela-S3	cervix
17	chr4:103332200-103332600	Enhancers	Monocytes-CD14+_RO01746	blood
18	chr4:103332200-103333400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
19	chr4:103332200-103333600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
20	chr4:103332200-103333600	Enhancers	Primary monocytes fromperipheralblood	blood
21	chr4:103332200-103333600	Enhancers	Hela-S3	cervix
22	chr4:103332200-103333600	Enhancers	NHDF-Ad	bronchial
23	chr4:103332400-103333000	Enhancers	Primary neutrophils fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links